Home > E. Pathology by systems > Genital system > Female genital system > Uterus > Uterine cervix > BD SurePath Pap Test

BD SurePath Pap Test

Thursday 8 December 2011

Webpage

The BD SurePath liquid-based Pap test is an FDA approved thin-layer cell preparation process intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses.